Election of Class III Director: Shannon Campbell
Election of Class III Director: Kapil Dhingra
To ratify the appointment of PricewaterhouseCoopers LLP as Black Diamond Therapeutics, Inc.s independent registered public accounting firm for the fiscal year ending December 31, 2026.
To approve, on a non-binding, advisory basis, the compensation of the Companys named executive officers.
Non-binding, advisory vote on the preferred frequency of future non-binding, advisory votes to approve the compensation of the Companys named executive officers.